United States · Platforms & data · MarketBeat
Analysts Issue Forecasts for Opus Genetics FY2029 Earnings
Detailed summary
Opus Genetics, Inc. (NASDAQ:IRD - Free Report) - Stock analysts at HC Wainwright raised their FY2029 EPS estimates for shares of Opus Genetics in a report issued on Wednesday, November 11th. HC Wainwright analyst M. Caufield now anticipates that the company will post earnings per share of $0.08 for
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)
